In this week’s Diario Medico Special on Diagnostic Therapies, IBEC acting director Josep Samitier’s expert opinion is quoted in an article about lab-on-a-chip technologies.
“Nanodiagnosis enables the identification of disease – or predisposition to disease – at the cellular or molecular level by the use of nanodevices,” he explains. “The ultimate goal is to identify the pathology at the earliest point possible. To achieve this, we need to develop nanotechnology research further to improve the efficiency, sensitivity and specificity of diagnostic systems both in vitro and in vivo.”
Read the article here.